Retrospective trial of long acting analogues detemir and degludec usage in children and adolescents to overcome glucose variability caused by dawn phenomenon and reverse dawn phenomenon

A. V. Vitebskaya; E. V. Shreder; A. V. Popovich; E. A. Pisareva

doi:10.14341/DM12431-9948

For citations:

Vitebskaya A.V., Shreder E.V., Popovich A.V., Pisareva E.A. Retrospective trial of long acting analogues detemir and degludec usage in children and adolescents to overcome glucose variability caused by dawn phenomenon and reverse dawn phenomenon. Diabetes mellitus. 2021;24(4):315-324. (In Russ.) https://doi.org/10.14341/DM12431

Views PDF (Rus): 0

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).

ISSN 2072-0351 (Print)
ISSN 2072-0378 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Diabetes mellitus

For citations:

Cookies policy